THRA and colorectal carcinoma: In silico analysis of 3238 bp of the THRA promoter region showed the presence of several putative binding sites for transcription factors, such as TCF7L2, RBPJ, and CDX2, that are fundamental to intestinal physiology and are altered in CRC [50] (Fig. 2).